Details of the Active Pharmaceutical Ingredient (API)
| General Information of API (ID: D00676) | |||||
|---|---|---|---|---|---|
| Name |
Tiludronic acid
|
||||
| Synonyms |
Click to Show/Hide the Synonyms of This API
Tiludronic Acid; Tiludronate; 89987-06-4; Skelid; Acide tiludronique [INN-French]; Acido tiludronico [INN-Spanish]; Acidum tiludronicum [INN-Latin]; UNII-6PNS59HP4Y; SR-41319; 6PNS59HP4Y; SR 41319; [(4-chlorophenyl)sulfanyl-phosphonomethyl]phosphonic acid; CHEBI:9598; Acidum tiludronicum; Acido tiludronico; Acide tiludronique; Tiludronic acid [INN:BAN]; CIPsMBP; Tiludronic acid (INN); Tiludronic acid disodium; (4-Chlorophenylthio)methylenediphosphonic acid; C08141; CHEMBL1350; SCHEMBL18988; (((p-Chlorophenyl)thio)methylene)diphosphonic acid; BIDD:GT0814; GTPL7604; Tiludronate disodium salt hydrate; DTXSID10237966; ZINC1531010; BDBM50442524; MFCD16872037; DB01133; FT-0630969; D08599; 987T064; Q2823312; BRD-K10845183-382-01-2; {[(4-chlorophenyl)sulfanyl](phosphono)methyl}phosphonic acid; [[(4-Chlorophenyl)thio]methylene]bisphosphonic acid disodium salt hydrate
|
||||
| Clinical Status |
Approved
|
||||
| Disease Indication | Osteoporosis | ICD-11: FB83 | [1] | ||
| PubChem CID | |||||
| Formula |
C7H9ClO6P2S
|
||||
| Canonical SMILES |
C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl
|
||||
| InChI |
1S/C7H9ClO6P2S/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14/h1-4,7H,(H2,9,10,11)(H2,12,13,14)
|
||||
| InChIKey |
DKJJVAGXPKPDRL-UHFFFAOYSA-N
|
||||
| Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=60937"></iframe>
|
![]() |
|||
| 3D MOL | 2D MOL | ||||
| Physicochemical Properties | Molecular Weight | 318.61 | Topological Polar Surface Area | 140 | |
| XlogP | -0.3 | Complexity | 324 | ||
| Heavy Atom Count | 17 | Rotatable Bond Count | 4 | ||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Full List of Drug Formulations (DFMs) Containing This API | ||||||
|---|---|---|---|---|---|---|
| Tiludronic acid 200 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Crospovidone
|
|||||
| Dosage Form | Oral Tablet | |||||
| Company | Sanofi-Aventis | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
| Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


